Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hematologic Neoplasms × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

Cyclophosphamide 31 fludarabine 23 fludarabine phosphate 22 Tacrolimus 22 Whole-Body Irradiation 21 Mycophenolic Acid 19 Busulfan 14 Melphalan 11 thymoglobulin 10 Methotrexate 10 Granulocyte Colony-Stimulating Factor 10 Antilymphocyte Serum 10 Stem Cell Transplantation 9 Rituximab 9 Filgrastim 8 Thiotepa 7 Cyclosporine 7 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6 Mesna 6 Cytarabine 6 Nivolumab 5 Bortezomib 5 Alemtuzumab 5 trametinib 4 Sirolimus 4 Hematopoietic Stem Cell Transplantation 4 Dexamethasone 4 Cyclosporins 4 venetoclax 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡